Shape Therapeutics is a pioneering biotechnology company based in Seattle, Washington, focused on developing programmable RNA medicines to address the genetic causes of diseases. By integrating advancements in artificial intelligence and RNA technology, ShapeTX is creating innovative solutions in RNA editing, next-generation AAVs, and gene therapy manufacturing. The company's platform empowers pharmaceutical innovators to design treatments for a variety of conditions, including rare genetic disorders and neurodegenerative diseases like Alzheimer’s and Parkinson’s. Committed to scientific excellence and diversity of thought, Shape Therapeutics aims to transform the landscape of gene therapy and make significant contributions to patient care.